Oruka Therapeutics (ORKA) Other Working Capital Changes (2010 - 2026)
Oruka Therapeutics' (ORKA) quarterly Other Working Capital Changes came in at -$125000.0 in Q1 2026, down 495.24% year-on-year from $31626.5 in Q1 2025, and down 725.0% quarter-over-quarter from $20000.0 in Q4 2025.
Oruka Therapeutics (ORKA) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Oruka Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$125000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes fell 495.24% year-over-year to -$125000.0 in Q1 2026; TTM through Mar 2026 was -$552000.0, a 1183.72% decrease from a year earlier, with the FY2025 full-year figure at -$448000.0, down 3100.0% from the prior year.
- Other Working Capital Changes eased to -$125000.0 in Q1 2026 per ORKA's latest filing, from $20000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $2.4 million in Q3 2025 and bottomed at -$852000.0 in Q4 2024.
- The 5-year median for Other Working Capital Changes is $148000.0 (2025), against an average of $219882.4.
- Biggest YoY gain for Other Working Capital Changes was 200.0% in 2025; the steepest drop was 22050.0% in 2025.
- Year by year, Other Working Capital Changes stood at -$20000.0 in 2024, then soared by 200.0% to $20000.0 in 2025, then tumbled by 725.0% to -$125000.0 in 2026.
- Per Business Quant, the three latest ORKA Other Working Capital Changes figures stand at -$125000.0 (Q1 2026), $20000.0 (Q4 2025), and -$439000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -461,000.00 |
| Mar 31, 2026 | -461,000.00 |
| Mar 31, 2026 | -461,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Dec 31, 2025 | 805,000.00 |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Sep 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 617,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Mar 31, 2025 | 148,000.00 |
| Dec 31, 2024 | -852,000.00 |
| Dec 31, 2024 | -852,000.00 |
| Dec 31, 2024 | -852,000.00 |
| Sep 30, 2024 | 259,000.00 |
| Sep 30, 2024 | 259,000.00 |